Charles Schwab’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Buy |
570,079
+45,593
| +9% | +$1.09M | ﹤0.01% | 1860 |
|
|
2025
Q1 | $13M | Buy |
524,486
+22,282
| +4% | +$554K | ﹤0.01% | 1833 |
|
|
2024
Q4 | $9.46M | Buy |
502,204
+70,307
| +16% | +$1.32M | ﹤0.01% | 2041 |
|
|
2024
Q3 | $6.5M | Buy |
431,897
+16,819
| +4% | +$253K | ﹤0.01% | 2239 |
|
|
2024
Q2 | $11.9M | Buy |
415,078
+927
| +0.2% | +$26.5K | ﹤0.01% | 1956 |
|
|
2024
Q1 | $12.1M | Buy |
414,151
+42,485
| +11% | +$1.24M | ﹤0.01% | 1897 |
|
|
2023
Q4 | $12.5M | Buy |
371,666
+11,696
| +3% | +$395K | ﹤0.01% | 1868 |
|
|
2023
Q3 | $11M | Buy |
359,970
+11,453
| +3% | +$351K | ﹤0.01% | 1862 |
|
|
2023
Q2 | $14M | Buy |
348,517
+633
| +0.2% | +$25.4K | ﹤0.01% | 1731 |
|
|
2023
Q1 | $14.2M | Buy |
347,884
+6,880
| +2% | +$281K | ﹤0.01% | 1700 |
|
|
2022
Q4 | $13.2M | Buy |
341,004
+9,229
| +3% | +$356K | ﹤0.01% | 1697 |
|
|
2022
Q3 | $17.6M | Buy |
331,775
+10,632
| +3% | +$566K | 0.01% | 1457 |
|
|
2022
Q2 | $18.7M | Sell |
321,143
-27,705
| -8% | -$1.62M | 0.01% | 1458 |
|
|
2022
Q1 | $26.6M | Sell |
348,848
-10,720
| -3% | -$818K | 0.01% | 1319 |
|
|
2021
Q4 | $21.6M | Buy |
359,568
+18,508
| +5% | +$1.11M | 0.01% | 1518 |
|
|
2021
Q3 | $19.1M | Buy |
341,060
+19,642
| +6% | +$1.1M | 0.01% | 1628 |
|
|
2021
Q2 | $19.5M | Buy |
321,418
+5,810
| +2% | +$353K | 0.01% | 1606 |
|
|
2021
Q1 | $22.1M | Sell |
315,608
-20,321
| -6% | -$1.42M | 0.01% | 1448 |
|
|
2020
Q4 | $20.1M | Buy |
335,929
+3,235
| +1% | +$194K | 0.01% | 1403 |
|
|
2020
Q3 | $20M | Sell |
332,694
-21,389
| -6% | -$1.29M | 0.01% | 1201 |
|
|
2020
Q2 | $18.6M | Buy |
354,083
+13,390
| +4% | +$703K | 0.01% | 1235 |
|
|
2020
Q1 | $11.4M | Buy |
340,693
+4,864
| +1% | +$163K | 0.01% | 1374 |
|
|
2019
Q4 | $15.2M | Buy |
335,829
+7,801
| +2% | +$353K | 0.01% | 1402 |
|
|
2019
Q3 | $12.5M | Buy |
328,028
+29,699
| +10% | +$1.13M | 0.01% | 1463 |
|
|
2019
Q2 | $13M | Buy |
298,329
+10,153
| +4% | +$442K | 0.01% | 1425 |
|
|
2019
Q1 | $11M | Buy |
288,176
+30,783
| +12% | +$1.17M | 0.01% | 1530 |
|
|
2018
Q4 | $11.1M | Buy |
257,393
+16,639
| +7% | +$716K | 0.01% | 1388 |
|
|
2018
Q3 | $11.8M | Buy |
240,754
+27,530
| +13% | +$1.35M | 0.01% | 1526 |
|
|
2018
Q2 | $6.83M | Buy |
213,224
+17,950
| +9% | +$575K | 0.01% | 1839 |
|
|
2018
Q1 | $6.08M | Buy |
195,274
+8,025
| +4% | +$250K | ﹤0.01% | 1835 |
|
|
2017
Q4 | $8.55M | Sell |
187,249
-1,428
| -0.8% | -$65.2K | 0.01% | 1592 |
|
|
2017
Q3 | $7.09M | Buy |
188,677
+9,977
| +6% | +$375K | 0.01% | 1689 |
|
|
2017
Q2 | $8.52M | Buy |
178,700
+13,973
| +8% | +$667K | 0.01% | 1474 |
|
|
2017
Q1 | $7.51M | Buy |
164,727
+3,015
| +2% | +$137K | 0.01% | 1509 |
|
|
2016
Q4 | $5.22M | Buy |
161,712
+33,272
| +26% | +$1.07M | 0.01% | 1716 |
|
|
2016
Q3 | $4.4M | Buy |
128,440
+6,012
| +5% | +$206K | 0.01% | 1734 |
|
|
2016
Q2 | $4.13M | Sell |
122,428
-9,182
| -7% | -$310K | 0.01% | 1689 |
|
|
2016
Q1 | $6.97M | Buy |
131,610
+1,645
| +1% | +$87.2K | 0.01% | 1296 |
|
|
2015
Q4 | $9.98M | Buy |
129,965
+3,703
| +3% | +$284K | 0.01% | 1024 |
|
|
2015
Q3 | $5.19M | Buy |
126,262
+8,522
| +7% | +$350K | 0.01% | 1444 |
|
|
2015
Q2 | $8.33M | Buy |
117,740
+3,269
| +3% | +$231K | 0.01% | 1180 |
|
|
2015
Q1 | $10.2M | Buy |
114,471
+6,776
| +6% | +$602K | 0.01% | 984 |
|
|
2014
Q4 | $9.55M | Buy |
107,695
+1,130
| +1% | +$100K | 0.01% | 927 |
|
|
2014
Q3 | $10.3M | Buy |
106,565
+14,018
| +15% | +$1.36M | 0.02% | 802 |
|
|
2014
Q2 | $8.5M | Buy |
92,547
+11,642
| +14% | +$1.07M | 0.01% | 966 |
|
|
2014
Q1 | $5.66M | Buy |
80,905
+4,457
| +6% | +$312K | 0.01% | 1233 |
|
|
2013
Q4 | $4.4M | Buy |
76,448
+3,165
| +4% | +$182K | 0.01% | 1373 |
|
|
2013
Q3 | $3.73M | Buy |
73,283
+10,772
| +17% | +$549K | 0.01% | 1412 |
|
|
2013
Q2 | $1.84M | Buy |
+62,511
| New | +$1.84M | ﹤0.01% | 1814 |
|